Child-friendly RTM therapy to reduce PTSD symptoms
Official title: Developing Innovative PTSD Treatment for Children: Reconsolidation of Traumatic Memories Protocol™ for Children (RTM-C Protocol)
Run by Global Institute for Mental Health Innovations, Networking and Development a.s.b.l. · NCT07185126 · Data updated 2026-11-12
This project will test whether a child-friendly Reconsolidation of Traumatic Memories protocol (RTM-C) can safely reduce PTSD symptoms in children aged 6–14 who have experienced trauma.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 14 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Global Institute for Mental Health Innovations, Networking and Development a.s.b.l. Academic / other |
| Locations | 1 site (Kyiv) |
| Status | Recruiting |
| Started | September 20, 2025 |
| Main results expected | February 20, 2027 |
| Study ends | August 20, 2027 |
| Registry record updated | September 16, 2026 |
| Trial ID | NCT07185126 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 6–14 with clinically significant PTSD symptoms (CATS-2 parent total ≥15), endorsed functional impairment, available caregiver consent, and ability to attend the parent session, six treatment sessions, and follow-ups are ideal candidates.
✕Probably not a fit
Children with acute comorbid psychiatric disorders, those already in concurrent trauma-focused psychotherapy, or those unable to follow session instructions due to cognitive impairment are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The RTM-C protocol adapts an adult memory reconsolidation therapy into child-friendly language, games, and animated tools to help children safely reprocess traumatic memories. Children and a caregiver attend an initial parent session, then the child receives up to six therapist-led sessions that use guided imagery and dissociative/regulatory steps. Outcomes include symptom change measured by parent-reported CATS-2, safety, and acceptability to children, parents, and therapists, with 1- and 6-month follow-ups. The intervention is brief, non-pharmacological, and delivered in-person at a single site.
Why it matters
Potential benefit: If successful, RTM-C could quickly reduce distressing memories, flashbacks, and nightmares and improve daily functioning for children with PTSD.
How similar studies have gone: The adult RTM Protocol™ has demonstrated strong clinical effectiveness in several trials, but the child-adapted RTM-C is novel and has limited prior testing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 6-14 years at enrolment. * PTSD symptoms present: CATS-2 (Parent) total ≥15 at screening. * Functional impact: impairment endorsed in ≥1 CATS-2 domain (relationships, leisure, learning, happiness). * Consent/assent: written parent/guardian consent and child assent obtained. * Availability: child and caregiver can attend parent session + 6 treatment sessions and complete 1- and 6-month follow-ups. * Language/comprehension: child can understand session instructions and participate in tasks (with supports as needed). * Therapist check of readiness: during Session 1 practice, child demonstrates reliable break state (disengages from imagery, re-orients to present, maintains eye contact, relaxed affect). Exclusion Criteria: * Acute comorbid mental disorder. * Concurrent trauma-focused psychotherapy planned or ongoing during the study period. * Inability to understand/follow instructions due to cognitive impairment or other reasons that preclude participation. * Medical/neurological condition or situational factors (e.g., inability to commit to visits) that, in the investigator's judgment, would make participation unsafe or compromise study integrity.
Where it's running
-
Charitable Foundation Voices of Children
Kyiv, Ukraine Recruiting
Study contacts
- Principal investigator: Viktoriia Gorbunova, ScD — Global Institute for Mental Health Innovations, Networking and Development
- Study coordinator: Viktoriia Gorbunova, ScD
- Email: viktoriyka.gorbunova@gmail.com
- Phone: +380931316322
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-invasive vagus nerve stimulation (gammaCore) for PTSD
This study will test whether the handheld gammaCore device, which delivers mild electrical stimulation to the vagus nerve through the neck, can help adults with PTSD reduce their symptoms.
-
Building Ukraine's strength in PTSD treatment
This project will try the Reconsolidation of Traumatic Memories (RTM) protocol alongside standard PTSD treatments to see if it reduces symptoms in adults with PTSD living in Ukraine.
-
Emotional dysregulation in adolescents with complex trauma traits
Researchers will observe teens to see how emotional dysregulation shows up in CPTSD and how it differs from BPD and PTSD.
-
Grappling with Trauma: BJJ for First Responders
This program tests whether eight weeks of Brazilian Jiu-Jitsu can be tied to changes in trauma-related symptoms for first responders who prefer movement-based activities over traditional mental health services.
-
Eye Movement Intervention with Different Memory Reactivation Procedures for Intrusive Traumatic Memories
This online trial tests whether combining eye movements with different memory reactivation tasks can reduce intrusive trauma memories in people with PTSD.
-
Trauma-informed Psilocybin-assisted psychotherapy for PTSD
This study tests whether adding psilocybin to trauma-focused psychotherapy helps people with PTSD see if the approach is safe and tolerable and whether symptoms improve.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.